Cargando…
Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial
Objective To determine whether the probiotic Lactobacillus reuteri DSM 17938 reduces crying or fussing in a broad community based sample of breastfed infants and formula fed infants with colic aged less than 3 months. Design Double blind, placebo controlled randomised trial. Setting Community based...
Autores principales: | Sung, Valerie, Hiscock, Harriet, Tang, Mimi L K, Mensah, Fiona K, Nation, Monica L, Satzke, Catherine, Heine, Ralf G, Stock, Amanda, Barr, Ronald G, Wake, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972414/ https://www.ncbi.nlm.nih.gov/pubmed/24690625 http://dx.doi.org/10.1136/bmj.g2107 |
Ejemplares similares
-
Probiotics to improve outcomes of colic in the community: Protocol for the Baby Biotics randomised controlled trial
por: Sung, Valerie, et al.
Publicado: (2012) -
Impact of Lactobacillus reuteri colonization on gut microbiota, inflammation, and crying time in infant colic
por: Nation, Monica L., et al.
Publicado: (2017) -
Lactobacillus reuteri DSM 17938 Probiotics May Increase CC-Chemokine Receptor 7 Expression in Infants Treated With for Colic
por: Savino, Francesco, et al.
Publicado: (2019) -
The Efficacy and Safety of the Probiotic Bacterium Lactobacillus reuteri DSM 17938 for Infantile Colic: A Meta-Analysis of Randomized Controlled Trials
por: Xu, Man, et al.
Publicado: (2015) -
Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic: Systematic review with network meta-analysis
por: Gutiérrez-Castrellón, Pedro, et al.
Publicado: (2017)